News

GPs call for increased allergy test access

13-Oct-08

Half of GPs believe the key to improving allergy services is to increase access to testing facilities in primary care, a survey has found.

Of the 204 GPs questioned as part of the research, 47 per cent believed that increased availability of allergy testing would reduce the need to refer patients to specialists. In addition, 64 per cent believed it would lead to more accurate diagnoses.

The survey also showed that 80 per cent of GPs believe that diagnosis and treatment of allergies should take place in primary care.

The research was conducted by Phadia, a company which develops allergy testing equipment. A spokesman for the company said that better testing for GPs would ensure patients could manage their own conditions, possibly by avoiding particular allergens, rather than taking medicine.

tom.moberly@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Green practice for nurses

With spiralling energy costs, it is important to adopt policies that can save money as well as the e... Read More

Diabetes Year of Care

A radical programme promises to transform care for people with diabetes, writes Fiona Barr. Read More

Improving health in schools Improving health in schools

Health and education are working together to improve young people's health and wellbeing, writes Sar... Read More

Show all articles

Latest Clinical Articles

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Clinical Review - Epilepsy

Dr Yvonne Hart, consultant neurologist, Oxford Radcliffe Hospitals NHS Trust Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

Humira for juvenile arthritis

The licence for Humira (adalimumab) has been extended to include the treatment of active polyarticul... Read more

Once daily quetiapine

Seroquel XL, a new prolonged release formulation of quetiapine available as 50mg, 200mg, 300mg and 4... Read more

Jobs